The single-cell opioid responses in the context of HIV (SCORCH) consortium.

Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J, et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113:1905–26.

pubmed: 29749059 doi: 10.1111/add.14234

Han B, Volkow ND, Compton WM, McCance-Katz EF. Reported heroin use, use disorder, and injection among adults in the United States, 2002-2018. JAMA. 2020;323:568–71.

pubmed: 32044936 pmcid: 7042840 doi: 10.1001/jama.2019.20844

Volkow ND, McLellan TA. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA. 2011;305:1346–7.

pubmed: 21467287 doi: 10.1001/jama.2011.369

Herlinger K, Lingford-Hughes A. Opioid use disorder and the brain: a clinical perspective. Addiction (Abingdon, England). 2022;117:495–505.

pubmed: 34228373 doi: 10.1111/add.15636

United Nations Office on Drugs and Crime (UNODC). World Drug Report. 2021. Available from: https://www.unodc.org/unodc/en/data-and-analysis/wdr2021.html

Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. 2023. Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

Volkow ND, Normand J. The international HIV/AIDS pandemic has been closely inter-twined with drug abuse and addiction from the time it began. Preface. Drug Alcohol Depend. 2013;132:S1.

de Cock KM, Jaffe HW, Curran JW. Reflections on 40 Years of AIDS. Emerg Infect Dis. 2021;27:1553.

pubmed: 34013858 pmcid: 8153860 doi: 10.3201/eid2706.210284

Sullivan PS, Satcher Johnson A, Pembleton ES, Stephenson R, Justice AC, Althoff KN, et al. Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses. Lancet. 2021;397:1095–106.

pubmed: 33617774 doi: 10.1016/S0140-6736(21)00395-0

Ellis R, Langford D, Masliah E. HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci. 2007;8:33–44.

pubmed: 17180161 doi: 10.1038/nrn2040

Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet. Glob Health. 2017;5:e1192–e1207.

Amin P, Douaihy A. Substance use disorders in people living with human immunodeficiency virus/AIDS. Nurs Clin N Am. 2018;53:57–65.

doi: 10.1016/j.cnur.2017.10.007

Ventuneac A, Hecht G, Forcht E, Duah BA, Tarar S, Langenbach B, et al. Chronic high risk prescription opioid use among persons with HIV. Front Sociol. 2021;6:645992.

pubmed: 34095287 pmcid: 8176351 doi: 10.3389/fsoc.2021.645992

Parker R, Stein DJ, Jelsma J. Pain in people living with HIV/AIDS: a systematic review. J Int AIDS Soc. 2014;17:18719.

pubmed: 24560338 pmcid: 3929991 doi: 10.7448/IAS.17.1.18719

Miaskowski C, Penko JM, Guzman D, Mattson JE, Bangsberg DR, Kushel MB. Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection. J Pain. 2011;12:1004–16.

pubmed: 21684218 pmcid: 3164738 doi: 10.1016/j.jpain.2011.04.002

Canan C, Alexander GC, Moore R, Murimi I, Chander G, Lau B. Medicaid trends in prescription opioid and non-opioid use by HIV status. Drug Alcohol Depend. 2019;197:141–8.

pubmed: 30825794 pmcid: 6530465 doi: 10.1016/j.drugalcdep.2018.11.034

Canan CE, Chander G, Monroe AK, Gebo KA, Moore RD, Agwu AL, et al. High-risk prescription opioid use among people living with HIV. J Acquir Immune Defic Syndr. 2018;78:283–90.

pubmed: 29601405 pmcid: 5997528 doi: 10.1097/QAI.0000000000001690

Lemons A, DeGroote N, Peréz A, Craw J, Nyaku M, Broz D, et al. Opioid misuse among HIV-positive adults in medical care: results from the Medical Monitoring Project, 2009-2014. J Acquir Immune Defic Syndr. 2019;80:127–34.

pubmed: 30383590 pmcid: 6357776 doi: 10.1097/QAI.0000000000001889

Merlin JS, Long D, Becker WC, Cachay ER, Christopoulos KA, Claborn K, et al. Brief report: the association of chronic pain and long-term opioid therapy with HIV treatment outcomes. J Acquir Immune Defic Syndr. 2018;79:77–82.

pubmed: 29771793 pmcid: 6092197 doi: 10.1097/QAI.0000000000001741

Edelman EJ, Gordon K, Becker WC, Goulet JL, Skanderson M, Gaither JR, et al. Receipt of opioid analgesics by HIV-infected and uninfected patients. J Gen Intern Med. 2013;28:82–90.

pubmed: 22895747 doi: 10.1007/s11606-012-2189-z

Hartzler B, Dombrowski JC, Crane HM, Eron JJ, Geng EH, Christopher Mathews W, et al. Prevalence and predictors of substance use disorders among HIV care enrollees in the United States. AIDS Behav. 2017;21:1138–48.

pubmed: 27738780 pmcid: 6089366 doi: 10.1007/s10461-016-1584-6

Tsao JCI, Plankey MW, Young MA. Pain, psychological symptoms and prescription drug misuse in HIV: a literature review. J Pain Manag. 2012;5:111.

pubmed: 23826434 pmcid: 3697768

Robinson-Papp J, Elliott K, Simpson DM, Morgello S. Problematic prescription opioid use in an HIV-infected cohort: the importance of universal toxicology testing. J Acquir Immune Defic Syndr. 2012;61:187–93.

pubmed: 22820804 pmcid: 3458135 doi: 10.1097/QAI.0b013e3182683c98

Vijayaraghavan M, Freitas D, Bangsberg DR, Miaskowski C, Kushel MB. Non-medical use of non-opioid psychotherapeutic medications in a community-based cohort of HIV-infected indigent adults. Drug Alcohol Depend. 2014;143:263–7.

pubmed: 25107312 pmcid: 4161633 doi: 10.1016/j.drugalcdep.2014.06.044

Becker WC, Gordon K, Jennifer Edelman E, Kerns RD, Crystal S, Dziura JD, et al. Trends in any and high-dose opioid analgesic receipt among aging patients with and without HIV. AIDS Behav. 2016;20:679–86.

pubmed: 26384973 pmcid: 5006945 doi: 10.1007/s10461-015-1197-5

Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. Psychiatry. 2018;5:987–1012.

Moore DJ, Blackstone K, Woods SP, Ellis RJ, Atkinson JH, Heaton RK, et al. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care. 2012;24:1504–13.

pubmed: 22530794 pmcid: 3466384 doi: 10.1080/09540121.2012.672718

Blackard JT, Sherman KE. Drugs of abuse and their impact on viral pathogenesis. Viruses. 2021;13:2387.

pubmed: 34960656 pmcid: 8707190 doi: 10.3390/v13122387

Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374:363–71.

pubmed: 26816013 pmcid: 6135257 doi: 10.1056/NEJMra1511480

Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol. 2009;15:360–70.

pubmed: 20175693 pmcid: 3078805 doi: 10.3109/13550280903131915

Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, et al. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol. 1997;42:963–72.

pubmed: 9403489 doi: 10.1002/ana.410420618

Nash B, Festa L, Lin C, Meucci O. Opioid and chemokine regulation of cortical synaptodendritic damage in HIV-associated neurocognitive disorders. Brain Res. 2019;1723:146409.

pubmed: 31465771 pmcid: 6766413 doi: 10.1016/j.brainres.2019.146409

Fitting S, Knapp PE, Zou S, Marks WD, Scott Bowers M, Akbarali HI, et al. Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na

pubmed: 25232120 pmcid: 4166164 doi: 10.1523/JNEUROSCI.5351-13.2014

Fitting S, Xu R, Bull C, Buch SK, El-Hage N, Nath A, et al. Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. Am J Pathol. 2010;177:1397–410.

pubmed: 20651230 pmcid: 2928972 doi: 10.2353/ajpath.2010.090945

Calipari ES, Bagot RC, Purushothaman I, Davidson TJ, Yorgason JT, Peña CJ, et al. In vivo imaging identifies temporal signature of D1 and D2 medium spiny neurons in cocaine reward. Proc Natl Acad Sci USA. 2016;113:2726–31.

pubmed: 26831103 pmcid: 4791010 doi: 10.1073/pnas.1521238113

Hearing MC, Jedynak J, Ebner SR, Ingebretson A, Asp AJ, Fischer RA, et al. Reversal of morphine-induced cell-type-specific synaptic plasticity in the nucleus accumbens shell blocks reinstatement. Proc Natl Acad Sci USA. 2016;113:757–62.

pubmed: 26739562 pmcid: 4725472 doi: 10.1073/pnas.1519248113

Chandra R, Chase Francis T, Konkalmatt P, Amgalan A, Gancarz AM, Dietz DM, et al. Opposing role for Egr3 in nucleus accumbens cell subtypes in cocaine action. J Neurosci. 2015;35:7927–37.

pubmed: 25995477 pmcid: 4438133 doi: 10.1523/JNEUROSCI.0548-15.2015

Lobo MK, Covington HE, Chaudhury D, Friedman AK, Sun HS, Damez-Werno D, et al. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science. 2010;330:385–90.

pubmed: 20947769 pmcid: 3011229 doi: 10.1126/science.1188472

Graziane NM, Sun S, Wright WJ, Jang D, Liu Z, Huang YH, et al. Opposing mechanisms mediate morphine- and cocaine-induced generation of silent synapses. Nat Neurosci. 2016;19:915–25.

pubmed: 27239940 pmcid: 4925174 doi: 10.1038/nn.4313

Kim J, Park BH, Lee JH, Park SK, Kim JH. Cell type-specific alterations in the nucleus accumbens by repeated exposures to cocaine. Biol Psychiatry. 2011;69:1026–34.

pubmed: 21377654 doi: 10.1016/j.biopsych.2011.01.013

Campbell RR, Kramár EA, Pham L, Beardwood JH, Augustynski AS, López AJ, et al. HDAC3 activity within the nucleus accumbens regulates cocaine-induced plasticity and behavior in a cell-type-specific manner. J Neurosci. 2021;41:2814–27.

pubmed: 33602824 pmcid: 8018887 doi: 10.1523/JNEUROSCI.2829-20.2021

Engeln M, Mitra S, Chandra R, Gyawali U, Fox ME, Dietz DM, et al. Sex-specific role for Egr3 in nucleus accumbens D2-medium spiny neurons following long-term abstinence from cocaine self-administration. Biol Psychiatry. 2020;87:992–1000.

pubmed: 31858986 doi: 10.1016/j.biopsych.2019.10.019

Martin JA, Werner CT, Mitra S, Zhong P, Wang ZJ, Gobira PH, et al. A novel role for the actin-binding protein drebrin in regulating opiate addiction. Nat Commun. 2019;10:4140.

pubmed: 31515501 pmcid: 6742638 doi: 10.1038/s41467-019-12122-8

Mews P, Cunningham AM, Scarpa J, Ramakrishnan A, Hicks EM, Bolnick S, et al. Convergent abnormalities in striatal gene networks in human cocaine use disorder and mouse cocaine administration models. Sci Adv. 2023;9:eadd8946.

pubmed: 36763659 pmcid: 9916993 doi: 10.1126/sciadv.add8946

Bossert JM, Stern AL, Theberge FRM, Cifani C, Koya E, Hope BT, et al. Ventral medial prefrontal cortex neuronal ensembles mediate context-induced relapse to heroin. Nat Neurosci. 2011;14:420–2.

pubmed: 21336273 pmcid: 3077927 doi: 10.1038/nn.2758

Moussawi K, Pacchioni A, Moran M, Olive MF, Gass JT, Lavin A, et al. N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci. 2009;12:182–9.

pubmed: 19136971 pmcid: 2661026 doi: 10.1038/nn.2250

Shen H, Moussawi K, Zhou W, Toda S, Kalivas PW. Heroin relapse requires long-term potentiation-like plasticity mediated by NMDA2b-containing receptors. Proc Natl Acad Sci USA. 2011;108:19407–12.

pubmed: 22084102 pmcid: 3228456 doi: 10.1073/pnas.1112052108

LaLumiere RT, Kalivas PW. Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci. 2008;28:3170–7.

pubmed: 18354020 pmcid: 6670700 doi: 10.1523/JNEUROSCI.5129-07.2008

Wolf ME. Synaptic mechanisms underlying persistent cocaine craving. Nat Rev Neurosci. 2016;17:351–65.

pubmed: 27150400 pmcid: 5466704 doi: 10.1038/nrn.2016.39

Lee BR, Dong Y. Cocaine-induced metaplasticity in the nucleus accumbens: silent synapse and beyond. Neuropharmacology. 2011;61:1060–9.

pubmed: 21232547 pmcid: 3090702 doi: 10.1016/j.neuropharm.2010.12.033

Koob GF. Neurobiology of opioid addiction: opponent process, hyperkatifeia, and negative reinforcement. Biol Psychiatry. 2020;87:44–53.

pubmed: 31400808 doi: 10.1016/j.biopsych.2019.05.023

Watanabe T, Yamamoto R, Maeda A, Nakagawa T, Minami M, Satoh M. Effects of excitotoxic lesions of the central or basolateral nucleus of the amygdala on naloxone-precipitated withdrawal-induced conditioned place aversion in morphine-dependent rats. Brain Res. 2002;958:423–8.

pubmed: 12470879 doi: 10.1016/S0006-8993(02)03468-6

Ciccocioppo R, Sanna PP, Weiss F. Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D(1) antagonists. Proc Natl Acad Sci USA. 2001;98:1976–81.

pubmed: 11172061 pmcid: 29367 doi: 10.1073/pnas.98.4.1976

Janak PH, Tye KM. From circuits to behaviour in the amygdala. Nature. 2015;517:284–92.

pubmed: 25592533 pmcid: 4565157 doi: 10.1038/nature14188

Fuchs RA, See RE. Basolateral amygdala inactivation abolishes conditioned stimulus- and heroin-induced reinstatement of extinguished heroin-seeking behavior in rats. Psychopharmacology. 2002;160:425–33.

pubmed: 11919670 doi: 10.1007/s00213-001-0997-7

Yuan K, Cao L, Xue YX, Luo YX, Liu XX, Kong FN, et al. Basolateral amygdala is required for reconsolidation updating of heroin-associated memory after prolonged withdrawal. Addict Biol. 2020;25:e12793.

pubmed: 31339209 doi: 10.1111/adb.12793

Marchant NJ, Kaganovsky K, Shaham Y, Bossert JM. Role of corticostriatal circuits in context-induced reinstatement of drug seeking. Brain Res. 2015;1628:219–32.

pubmed: 25199590 doi: 10.1016/j.brainres.2014.09.004

Shen HW, Scofield MD, Boger H, Hensley M, Kalivas PW. Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse. J Neurosci. 2014;34:5649–57.

pubmed: 24741055 pmcid: 3988415 doi: 10.1523/JNEUROSCI.4564-13.2014

Lewitus GM, Konefal SC, Greenhalgh AD, Pribiag H, Augereau K, Stellwagen D. Microglial TNF-α suppresses cocaine-induced plasticity and behavioral sensitization. Neuron. 2016;90:483–91.

pubmed: 27112496 pmcid: 4860141 doi: 10.1016/j.neuron.2016.03.030

Walker DM, Cates HM, Loh YHE, Purushothaman I, Ramakrishnan A, Cahill KM, et al. Cocaine self-administration alters transcriptome-wide responses in the brain’s reward circuitry. Biol Psychiatry. 2018;84:867–80.

pubmed: 29861096 pmcid: 6202276 doi: 10.1016/j.biopsych.2018.04.009

Salery M, Dos Santos M, Saint-Jour E, Moumné L, Pagès C, Kappès V, et al. Activity-regulated cytoskeleton-associated protein accumulates in the nucleus in response to cocaine and acts as a brake on chromatin remodeling and long-term behavioral alterations. Biol Psychiatry. 2017;81:573–84.

pubmed: 27567310 doi: 10.1016/j.biopsych.2016.05.025

Grueter BA, Robison AJ, Neve RL, Nestler EJ, Malenka RC. ∆FosB differentially modulates nucleus accumbens direct and indirect pathway function. Proc Natl Acad Sci USA. 2013;110:1923–8.

pubmed: 23319622 pmcid: 3562792 doi: 10.1073/pnas.1221742110

McDaid J, Dallimore JE, Mackie AR, Napier TC. Changes in accumbal and pallidal pCREB and deltaFosB in morphine-sensitized rats: correlations with receptor-evoked electrophysiological measures in the ventral pallidum. Neuropsychopharmacology. 2006;31:1212–26.

pubmed: 16123760 doi: 10.1038/sj.npp.1300854

Piechota M, Korostynski M, Solecki W, Gieryk A, Slezak M, Bilecki W, et al. The dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum. Genome Biol. 2010;11:R48.

pubmed: 20459597 pmcid: 2898085 doi: 10.1186/gb-2010-11-5-r48

Zachariou V, Bolanos CA, Selley DE, Theobald D, Cassidy MP, Kelz MB, et al. An essential role for DeltaFosB in the nucleus accumbens in morphine action. Nat Neurosci. 2006;9:205–11.

pubmed: 16415864 doi: 10.1038/nn1636

Carpenter MD, Hu Q, Bond AM, Lombroso SI, Czarnecki KS, Lim CJ, et al. Nr4a1 suppresses cocaine-induced behavior via epigenetic regulation of homeostatic target genes. Nat Commun. 2020;11:504.

pubmed: 31980629 pmcid: 6981219 doi: 10.1038/s41467-020-14331-y

Xu H, Brown AN, Waddell NJ, Liu X, Kaplan GJ, Chitaman JM, et al. Role of long noncoding RNA Gas5 in cocaine action. Biol Psychiatry. 2020;88:758–66.

pubmed: 32711952 pmcid: 7584769 doi: 10.1016/j.biopsych.2020.05.004

Hollander JA, Im HI, Amelio AL, Kocerha J, Bali P, Lu Q, et al. Striatal microRNA controls cocaine intake through CREB signalling. Nature. 2010;466:197–202.

pubmed: 20613834 pmcid: 2916751 doi: 10.1038/nature09202

Heller EA, Kaska S, Fallon B, Ferguson D, Kennedy PJ, Neve RL, et al. Morphine and cocaine increase serum- and glucocorticoid-inducible kinase 1 activity in the ventral tegmental area. J Neurochem. 2015;132:243–53.

pubmed: 25099208 doi: 10.1111/jnc.12925

McGinty JF, Whitfield TW, Berglind WJ. Brain-derived neurotrophic factor and cocaine addiction. Brain Res. 2010;1314:183–93.

pubmed: 19732758 doi: 10.1016/j.brainres.2009.08.078

Koo JW, Mazei-Robison MS, Chaudhury D, Juarez B, LaPlant Q, Ferguson D, et al. BDNF is a negative modulator of morphine action. Science. 2012;338:124–8.

pubmed: 23042896 pmcid: 3547365 doi: 10.1126/science.1222265

López AJ, Siciliano CA, Calipari ES. Activity-dependent epigenetic remodeling in cocaine use disorder. Handb Exp Pharmacol. 2020;258:231–63.

pubmed: 31628597 doi: 10.1007/164_2019_257

Levine AA, Guan Z, Barco A, Xu S, Kandel ER, Schwartz JH. CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum. Proc Natl Acad Sci USA. 2005;102:19186–91.

pubmed: 16380431 pmcid: 1323217 doi: 10.1073/pnas.0509735102

Kumar A, Choi KH, Renthal W, Tsankova NM, Theobald DEH, Truong HT, et al. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron. 2005;48:303–14.

pubmed: 16242410 doi: 10.1016/j.neuron.2005.09.023

Browne CJ, Godino A, Salery M, Nestler EJ. Epigenetic mechanisms of opioid addiction. Biol Psychiatry. 2020;87:22–33.

pubmed: 31477236 doi: 10.1016/j.biopsych.2019.06.027

Egervari G, Landry J, Callens J, Fullard JF, Roussos P, Keller E, et al. Striatal H3K27 Acetylation Linked to Glutamatergic Gene Dysregulation in Human Heroin Abusers Holds Promise as Therapeutic Target. Biol Psychiatry. 2017;81:585–94.

pubmed: 27863698 doi: 10.1016/j.biopsych.2016.09.015

Jing L, Luo J, Zhang M, Qin WJ, Li YL, Liu Q, et al. Effect of the histone deacetylase inhibitors on behavioural sensitization to a single morphine exposure in mice. Neurosci Lett. 2011;494:169–73.

pubmed: 21396430 doi: 10.1016/j.neulet.2011.03.005

Chen WS, Xu WJ, Zhu HQ, Gao L, Lai MJ, Zhang FQ, et al. Effects of histone deacetylase inhibitor sodium butyrate on heroin seeking behavior in the nucleus accumbens in rats. Brain Res. 2016;1652:151–7.

pubmed: 27742468 doi: 10.1016/j.brainres.2016.10.007

Ferguson D, Koo JW, Feng J, Heller E, Rabkin J, Heshmati M, et al. Essential role of SIRT1 signaling in the nucleus accumbens in cocaine and morphine action. J Neurosci. 2013;33:16088–98.

pubmed: 24107942 pmcid: 3792451 doi: 10.1523/JNEUROSCI.1284-13.2013

Taniguchi M, Carreira MB, Smith LN, Zirlin BC, Neve RL, Cowan CW. Histone deacetylase 5 limits cocaine reward through cAMP-induced nuclear import. Neuron. 2012;73:108–20.

pubmed: 22243750 pmcid: 3259532 doi: 10.1016/j.neuron.2011.10.032

Penrod RD, Carreira MB, Taniguchi M, Kumar J, Maddox SA, Cowan CW. Novel role and regulation of HDAC4 in cocaine-related behaviors. Addict Biol. 2018;23:653–64.

pubmed: 28635037 doi: 10.1111/adb.12522

Renthal W, Maze I, Krishnan V, Covington HE, Xiao G, Kumar A, et al. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron. 2007;56:517–29.

pubmed: 17988634 doi: 10.1016/j.neuron.2007.09.032

Malvaez M, Mhillaj E, Matheos DP, Palmery M, Wood MA. CBP in the nucleus accumbens regulates cocaine-induced histone acetylation and is critical for cocaine-associated behaviors. J Neurosci. 2011;31:16941–8.

pubmed: 22114264 pmcid: 3235434 doi: 10.1523/JNEUROSCI.2747-11.2011

Maze I, Covingtoni HE, Dietz DM, Laplant Q, Renthal W, Russo SJ, et al. Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science. 2010;327:213–6.

pubmed: 20056891 pmcid: 2820240 doi: 10.1126/science.1179438

Zhang Z, Tao W, Hou YY, Wang W, Kenny PJ, Pan ZZ. MeCP2 repression of G9a in regulation of pain and morphine reward. J Neurosci. 2014;34:9076–87.

pubmed: 24990928 pmcid: 4078085 doi: 10.1523/JNEUROSCI.4194-13.2014

Sun HS, Maze I, Dietz DM, Scobie KN, Kennedy PJ, Damez-Werno D, et al. Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 dimethylation in the nucleus accumbens. J Neurosci. 2012;32:17454–64.

pubmed: 23197736 pmcid: 3516048 doi: 10.1523/JNEUROSCI.1357-12.2012

Massart R, Barnea R, Dikshtein Y, Suderman M, Meir O, Hallett M, et al. Role of DNA methylation in the nucleus accumbens in incubation of cocaine craving. J Neurosci. 2015;35:8042–58.

pubmed: 26019323 pmcid: 6605346 doi: 10.1523/JNEUROSCI.3053-14.2015

Imperio CG, McFalls AJ, Hadad N, Blanco-Berdugo L, Masser DR, Colechio EM, et al. Exposure to environmental enrichment attenuates addiction-like behavior and alters molecular effects of heroin self-administration in rats. Neuropharmacology. 2018;139:26–40.

pubmed: 29964093 pmcid: 6067959 doi: 10.1016/j.neuropharm.2018.06.037

Barrow TM, Byun HM, Li X, Smart C, Wang YX, Zhang Y, et al. The effect of morphine upon DNA methylation in ten regions of the rat brain. Epigenetics. 2017;12:1038–47.

pubmed: 29111854 doi: 10.1080/15592294.2017.1398296

Zipperly ME, Sultan FA, Graham GE, Brane AC, Simpkins NA, Carullo NVN, et al. Regulation of dopamine-dependent transcription and cocaine action by Gadd45b. Neuropsychopharmacology. 2021;46:709–20.

pubmed: 32927466 doi: 10.1038/s41386-020-00828-z

Zayyad Z, Spudich S. Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND). Curr HIV/AIDS Rep. 2015;12:16–24.

pubmed: 25604237 pmcid: 4741099 doi: 10.1007/s11904-014-0255-3

Nottet HS, Persidsky Y, Sasseville VG, Nukuna AN, Bock P, Zhai QH, et al. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol. 1996;156:1284–95.

pubmed: 8558009 doi: 10.4049/jimmunol.156.3.1284

León-Rivera R, Veenstra M, Donoso M, Tell E, Berman JW, Eugenin EA, et al. Central nervous system (CNS) viral seeding by mature monocytes and potential therapies to reduce CNS viral reservoirs in the cART era. MBio. 2021;12:1–17.

doi: 10.1128/mBio.03633-20

Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–99.

pubmed: 17914061 doi: 10.1212/01.WNL.0000287431.88658.8b

Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, et al. HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment. Nat Rev Neurol. 2016;12:309.

pubmed: 27080521 pmcid: 5842923 doi: 10.1038/nrneurol.2016.53

Gelman BB. Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered. Curr HIV/AIDS Rep. 2015;12:272–9.

pubmed: 25860316 pmcid: 4427627 doi: 10.1007/s11904-015-0266-8

Paolicelli RC, Sierra A, Stevens B, Tremblay ME, Aguzzi A, Ajami B, et al. Microglia states and nomenclature: a field at its crossroads. Neuron. 2022;110:3458–83.

pubmed: 36327895 pmcid: 9999291 doi: 10.1016/j.neuron.2022.10.020

Marban C, Forouzanfar F, Ait-Ammar A, Fahmi F, El Mekdad H, Daouad F, et al. Targeting the brain reservoirs: toward an HIV Cure. Front Immunol. 2016;7:397.

pubmed: 27746784 pmcid: 5044677 doi: 10.3389/fimmu.2016.00397

Rao VR, Ruiz AP, Prasad VR. Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND). AIDS Res Ther. 2014;11:13.

pubmed: 24894206 pmcid: 4043700 doi: 10.1186/1742-6405-11-13

Bagashev A, Sawaya BE. Roles and functions of HIV-1 Tat protein in the CNS: an overview. Virol J. 2013;10:358.

pubmed: 24359561 pmcid: 3879180 doi: 10.1186/1743-422X-10-358

Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 2001;410:988–94.

pubmed: 11309629 doi: 10.1038/35073667

Ye X, Zhang Y, Xu Q, Zheng H, Wu X, Qiu J, et al. HIV-1 Tat inhibits EAAT-2 through AEG-1 upregulation in models of HIV-associated neurocognitive disorder. Oncotarget. 2017;8:39922–34.

pubmed: 28404980 pmcid: 5503662 doi: 10.18632/oncotarget.16485

Plaza-Jennings AL, Valada A, O’Shea C, Iskhakova M, Hu B, Javidfar B, et al. HIV integration in the human brain is linked to microglial activation and 3D genome remodeling. Mol Cell. 2022;82:4647–63.e8.

pubmed: 36525955 pmcid: 9831062 doi: 10.1016/j.molcel.2022.11.016

Nickoloff-Bybel EA, Calderon TM, Gaskill PJ, Berman JW. HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System. J Neuroimmune Pharmacol. 2020;15:729–42.

pubmed: 32506353 pmcid: 7905900 doi: 10.1007/s11481-020-09927-6

Itoh K, Mehraein P, Weis S. Neuronal damage of the substantia nigra in HIV-1 infected brains. Acta Neuropathol. 2000;99:376–84.

pubmed: 10787036 doi: 10.1007/s004010051139

Aylward EH, Henderer JD, Mcarthur JC, Brettschneider PD, Harris GJ, Barta PE, et al. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology. 1993;43:2099–104.

pubmed: 8413973 doi: 10.1212/WNL.43.10.2099

Kumar AM, Ownby RL, Waldrop-Valverde D, Fernandez B, Kumar M. Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance. J Neurovirol. 2011;17:26–40.

pubmed: 21165787 doi: 10.1007/s13365-010-0003-4

Chang L, Wang GJ, Volkow ND, Ernst T, Telang F, Logan J, et al. Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. Neuroimage. 2008;42:869–78.

pubmed: 18579413 doi: 10.1016/j.neuroimage.2008.05.011

Larsson M, Hagberg L, Forsman A, Norkrans G. Cerebrospinal fluid catecholamine metabolites in HIV-infected patients. J Neurosci Res. 1991;28:406–9.

pubmed: 1856886 doi: 10.1002/jnr.490280313

Shah S, Sinharay S, Matsuda K, Schreiber-Stainthorp W, Muthusamy S, Lee D, et al. Potential mechanism for HIV-associated depression: upregulation of serotonin transporters in SIV-infected macaques detected by 11C-DASB PET. Front Psychiatry. 2019;10:362.

pubmed: 31178771 pmcid: 6543249 doi: 10.3389/fpsyt.2019.00362

Rabkin JG, Wagner GJ, Rabkin R. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial. Am J Psychiatry. 1999;156:101–7.

pubmed: 9892304 doi: 10.1176/ajp.156.1.101

Shirazi J, Shah S, Sagar D, Nonnemacher MR, Wigdahl B, Khan ZK, et al. Epigenetics, drugs of abuse, and the retroviral promoter. J Neuroimmune Pharmacol. 2013;8:1181–96.

pubmed: 24218017 doi: 10.1007/s11481-013-9508-y

Bushman F, Lewinski M, Ciuffi A, Barr S, Leipzig J, Hannenhalli S, et al. Genome-wide analysis of retroviral DNA integration. Nat Rev Microbiol. 2005;3:848–58.

pubmed: 16175173 doi: 10.1038/nrmicro1263

Ding D, Qu X, Li L, Zhou X, Liu S, Lin S, et al. Involvement of histone methyltransferase GLP in HIV-1 latency through catalysis of H3K9 dimethylation. Virology. 2013;440:182–9.

pubmed: 23541084 doi: 10.1016/j.virol.2013.02.022

Friedman J, Cho W-K, Chu CK, Keedy KS, Archin NM, Margolis DM, et al. Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2. J Virol. 2011;85:9078–89.

pubmed: 21715480 pmcid: 3165831 doi: 10.1128/JVI.00836-11

Kauder SE, Bosque A, Lindqvist A, Planelles V, Verdin E. Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog. 2009;5:e1000495.

pubmed: 19557157 pmcid: 2695767 doi: 10.1371/journal.ppat.1000495

Blazkova J, Trejbalova K, Gondois-Rey F, Halfon P, Philibert P, Guiguen A, et al. CpG methylation controls reactivation of HIV from latency. PLoS Pathog. 2009;5:e1000554.

pubmed: 19696893 pmcid: 2722084 doi: 10.1371/journal.ppat.1000554

Churchill MJ, Cowley DJ, Wesselingh SL, Gorry PR, Gray LR. HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research. J Neurovirol. 2015;21:290–300.

pubmed: 25060300 doi: 10.1007/s13365-014-0271-5

Zadina JE, Nilges MR, Morgenweck J, Zhang X, Hackler L, Fasold MB. Endomorphin analog analgesics with reduced abuse liability, respiratory depression, motor impairment, tolerance, and glial activation relative to morphine. Neuropharmacology. 2016;105:215–27.

pubmed: 26748051 doi: 10.1016/j.neuropharm.2015.12.024

El-Hage N, Gurwell JA, Singh IN, Knapp PE, Nath A, Hauser KF. Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia. 2005;50:91–106.

pubmed: 15630704 pmcid: 4301446 doi: 10.1002/glia.20148

El-Hage N, Wu G, Wang J, Ambati J, Knapp PE, Reed JL, et al. HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia. 2006;53:132–46.

pubmed: 16206161 pmcid: 3077280 doi: 10.1002/glia.20262

Hu S, Sheng WS, Lokensgard JR, Peterson PK. Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. J Infect Dis. 2005;191:886–9.

pubmed: 15717263 doi: 10.1086/427830

Bruce-Keller AJ, Turchan-Cholewo J, Smart EJ, Geurin T, Chauhan A, Reid R, et al. Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice. Glia. 2008;56:1414–27.

pubmed: 18551626 pmcid: 2725184 doi: 10.1002/glia.20708

Gurwell JA, Nath A, Sun Q, Zhang J, Martin KM, Chen Y, et al. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience. 2001;102:555–63.

pubmed: 11226693 doi: 10.1016/S0306-4522(00)00461-9

Fitting S, Zou S, Chen W, Vo P, Hauser KF, Knapp PE. Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis. J Proteome Res. 2010;9:1795–804.

pubmed: 20121167 pmcid: 2856623 doi: 10.1021/pr900926n

Khurdayan VK, Buch S, El-Hage N, Lutz SE, Goebel SM, Singh IN, et al. Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. Eur J Neurosci. 2004;19:3171–82.

pubmed: 15217373 pmcid: 4305445 doi: 10.1111/j.0953-816X.2004.03461.x

El-Hage N, Bruce-Keller AJ, Yakovleva T, Bazov I, Bakalkin G, Knapp PE, et al. Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca(2+)](i), NF-kappaB trafficking and transcription. PLoS ONE. 2008;3:e4093.

Turchan-Cholewo J, Dimayuga FO, Ding Q, Keller JN, Hauser KF, Knapp PE, et al. Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. J Neurosci Res. 2008;86:2100–10.

pubmed: 18338799 pmcid: 2760290 doi: 10.1002/jnr.21653

El-Hage N, Bruce-Keller AJ, Knapp PE, Hauser KF. CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice. J Neuroimmune Pharmacol. 2008;3:275–85.

pubmed: 18815890 pmcid: 2722754 doi: 10.1007/s11481-008-9127-1

Turchan-Cholewo J, Dimayuga FO, Gupta S, Keller JN, Knapp PE, Hauser KF, et al. Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation. J Neurochem. 2009;108:202–15.

pubmed: 19054280 doi: 10.1111/j.1471-4159.2008.05756.x

Dutta R, Roy S. Chronic morphine and HIV-1 Tat promote differential central nervous system trafficking of CD3+ and Ly6C+ immune cells in a murine Streptococcus pneumoniae infection model. J Neuroinflammation. 2015;12:120.

pubmed: 26087960 pmcid: 4490693 doi: 10.1186/s12974-015-0341-5

Coley JS, Calderon TM, Gaskill PJ, Eugenin EA, Berman JW. Dopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesis. PLoS ONE. 2015;10:e0117450.

pubmed: 25647501 pmcid: 4315499 doi: 10.1371/journal.pone.0117450

Hauser KF, Knapp PE. Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors. Int Rev Neurobiol. 2014;118:231–313.

pubmed: 25175867 pmcid: 4304845 doi: 10.1016/B978-0-12-801284-0.00009-9

Nam MH, Han KS, Lee J, Bae JY, An H, Park S, et al. Expression of µ-opioid receptor in CA1 hippocampal astrocytes. Exp Neurobiol. 2018;27:120–8.

pubmed: 29731678 pmcid: 5934543 doi: 10.5607/en.2018.27.2.120

Banerjee A, Li L, Pirrone V, Krebs FC, Wigdahl B, Nonnemacher MR. cAMP signaling enhances HIV-1 long terminal repeat (LTR)-directed transcription and viral replication in bone marrow progenitor cells. Clin Med Insights Pathol. 2017;10:1179555717694535.

pubmed: 28469516 pmcid: 5398651 doi: 10.1177/1179555717694535

Saunders A, Macosko EZ, Wysoker A, Goldman M, Krienen FM, de Rivera H, et al. Molecular diversity and specializations among the cells of the adult mouse brain. Cell. 2018;174:1015–30.e16.

pubmed: 30096299 pmcid: 6447408 doi: 10.1016/j.cell.2018.07.028

Callaway EM, Dong H-W, Ecker JR, Hawrylycz MJ, Huang ZJ, Lein ES, et al. A multimodal cell census and atlas of the mammalian primary motor cortex. Nature. 2021;598:86.

doi: 10.1038/s41586-021-03950-0

Mukamel EA, Ngai J. Perspectives on defining cell types in the brain. Curr Opin Neurobiol. 2019;56:61–68.

pubmed: 30530112 doi: 10.1016/j.conb.2018.11.007

Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, et al. Single-cell transcriptomic analysis of Alzheimer’s disease. Nature. 2019;570:332–7.

pubmed: 31042697 pmcid: 6865822 doi: 10.1038/s41586-019-1195-2

Velmeshev D, Schirmer L, Jung D, Haeussler M, Perez Y, Mayer S, et al. Single-cell genomics identifies cell type-specific molecular changes in autism. Science. 2019;364:685–9.

pubmed: 31097668 pmcid: 7678724 doi: 10.1126/science.aav8130

Brenner E, Tiwari GR, Kapoor M, Liu Y, Brock A, Mayfield RD. Single cell transcriptome profiling of the human alcohol-dependent brain. Hum Mol Genet. 2020;29:1144–53.

pubmed: 32142123 pmcid: 7206851 doi: 10.1093/hmg/ddaa038

Yao Z, Liu H, Xie F, Fischer S, Adkins RS, Aldridge AI, et al. A transcriptomic and epigenomic cell atlas of the mouse primary motor cortex. Nature. 2021;598:103.

pubmed: 34616066 pmcid: 8494649 doi: 10.1038/s41586-021-03500-8

Boldog E, Bakken TE, Hodge RD, Novotny M, Aevermann BD, Baka J, et al. Transcriptomic and morphophysiological evidence for a specialized human cortical GABAergic cell type. Nat Neurosci. 2018;21:1185–95.

pubmed: 30150662 pmcid: 6130849 doi: 10.1038/s41593-018-0205-2

Habib N, Li Y, Heidenreich M, Swiech L, Avraham-Davidi I, Trombetta JJ, et al. Div-Seq: Single-nucleus RNA-Seq reveals dynamics of rare adult newborn neurons. Science. 2016;353:925–8.

pubmed: 27471252 pmcid: 5480621 doi: 10.1126/science.aad7038

Habib N, Avraham-Davidi I, Basu A, Burks T, Shekhar K, Hofree M, et al. Massively parallel single-nucleus RNA-seq with DroNc-seq. Nat Methods. 2017;14:955–8.

pubmed: 28846088 pmcid: 5623139 doi: 10.1038/nmeth.4407

Lake BB, Ai R, Kaeser GE, Salathia NS, Yung YC, Liu R, et al. Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain. Science. 2016;352:1586–90.

pubmed: 27339989 pmcid: 5038589 doi: 10.1126/science.aaf1204

Nguyen AT, Wang K, Hu G, Wang X, Miao Z, Azevedo JA, et al. APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer’s disease. Acta Neuropathol. 2020;140:477–93.

pubmed: 32840654 pmcid: 7520051 doi: 10.1007/s00401-020-02200-3

Slyper M, Porter CBM, Ashenberg O, Waldman J, Drokhlyansky E, Wakiro I, et al. A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nat Med. 2020;26:792–802.

pubmed: 32405060 pmcid: 7220853 doi: 10.1038/s41591-020-0844-1

Tran MN, Maynard KR, Spangler A, Huuki LA, Montgomery KD, Sadashivaiah V, et al. Single-nucleus transcriptome analysis reveals cell-type-specific molecular signatures across reward circuitry in the human brain. Neuron. 2021;109:3088–3103.e5.

pubmed: 34582785 pmcid: 8564763 doi: 10.1016/j.neuron.2021.09.001

Stanley G, Gokce O, Malenka RC, Südhof TC, Quake SR. Continuous and discrete neuron types of the adult murine striatum. Neuron. 2020;105:688–699.e8.

pubmed: 31813651 doi: 10.1016/j.neuron.2019.11.004

O’leary TP, Sullivan KE, Wang L, Clements J, Lemire AL, Cembrowski MS. Extensive and spatially variable within-cell-type heterogeneity across the basolateral amygdala. Elife. 2020;9:1–27.

Chen R, Blosser TR, Djekidel MN, Hao J, Bhattacherjee A, Chen W, et al. Decoding molecular and cellular heterogeneity of mouse nucleus accumbens. Nat Neurosci. 2021;24:1757–71.

pubmed: 34663959 pmcid: 8639815 doi: 10.1038/s41593-021-00938-x

Luo C, Keown CL, Kurihara L, Zhou J, He Y, Li J, et al. Single-cell methylomes identify neuronal subtypes and regulatory elements in mammalian cortex. Science. 2017;357:600–4.

pubmed: 28798132 pmcid: 5570439 doi: 10.1126/science.aan3351

Liu H, Zhou J, Tian W, Luo C, Bartlett A, Aldridge A, et al. DNA methylation atlas of the mouse brain at single-cell resolution. BioRxiv. 2020. https://doi.org/10.1101/2020.04.30.069377 .

Gokce O, Stanley GM, Treutlein B, Neff NF, Camp JG, Malenka RC, et al. Cellular Taxonomy of the Mouse Striatum as Revealed by Single-Cell RNA-Seq. Cell Rep. 2016;16:1126–37.

pubmed: 27425622 pmcid: 5004635 doi: 10.1016/j.celrep.2016.06.059

Phillips RA, Wan E, Tuscher JJ, Reid D, Drake OR, Ianov L, et al. Temporally specific gene expression and chromatin remodeling programs regulate a conserved Pdyn enhancer. Elife. 2023;12. https://doi.org/10.1101/2023.06.02.543489 .

Bhatia P, Yang L, Luo JXJ, Xu M, Renthal W. Epigenomic profiling of mouse nucleus accumbens at single-cell resolution. Mol Cell Neurosci. 2023;126:103857.

pubmed: 37137383 doi: 10.1016/j.mcn.2023.103857

He J, Kleyman M, Chen J, Alikaya A, Rothenhoefer KM, Ozturk BE, et al. Transcriptional and anatomical diversity of medium spiny neurons in the primate striatum. Curr Biol. 2021;31:5473–86.e6.

pubmed: 34727523 pmcid: 9359438 doi: 10.1016/j.cub.2021.10.015

Matsushima A, Pineda SS, Crittenden JR, Lee H, Galani K, Mantero J, et al. Transcriptional vulnerabilities of striatal neurons in human and rodent models of Huntington’s disease. Nat Commun. 2023;14:282.

pubmed: 36650127 pmcid: 9845362 doi: 10.1038/s41467-022-35752-x

Liu H, Zhou J, Tian W, Luo C, Bartlett A, Aldridge A, et al. DNA methylation atlas of the mouse brain at single-cell resolution. Nature. 2021;598:120–8.

pubmed: 34616061 pmcid: 8494641 doi: 10.1038/s41586-020-03182-8

Miller JA, Gouwens NW, Tasic B, Collman F, Tj Van Velthoven C, Bakken TE, et al. Common cell type nomenclature for the mammalian brain. ElifesciencesOrg. https://doi.org/10.7554/eLife.59928 .

Day JJ, Martinowich K. Single-cell transcriptional profiling in brain reward structures. Neuropsychopharmacology. 2023;48:243–4.

pubmed: 35915230 doi: 10.1038/s41386-022-01394-2

Yan Y, Herlihy B, Boyles S, Tao J, Hulme W, Roy S. Transcriptomic prooling of mouse amygdala during opioid dependence and withdrawal by single-cell RNA sequencing. 2022. 2022. https://doi.org/10.21203/rs.3.rs-1299708/v1 .

Savell KE, Tuscher JJ, Zipperly ME, Duke CG, Phillips RA, Bauman AJ, et al. A dopamine-induced gene expression signature regulates neuronal function and cocaine response. Sci Adv. 2020;6:eaba4221.

pubmed: 32637607 pmcid: 7314536 doi: 10.1126/sciadv.aba4221

Niu M, Morsey B, Lamberty BG, Emanuel K, Yu F, León-Rivera R, et al. Methamphetamine increases the proportion of SIV-infected microglia/macrophages, alters metabolic pathways, and elevates cell death pathways: a single-cell analysis. Viruses. 2020;12:1297.

pubmed: 33198269 pmcid: 7697917 doi: 10.3390/v12111297

Phillips RA, Tuscher JJ, Fitzgerald ND, Wan E, Zipperly ME, Duke CG, et al. Distinct subpopulations of D1 medium spiny neurons exhibit unique transcriptional responsiveness to cocaine. Mol Cell Neurosci. 2023;125:103849.

pubmed: 36965548 pmcid: 10898607 doi: 10.1016/j.mcn.2023.103849

Avey D, Sankararaman S, Yim AKY, Barve R, Milbrandt J, Mitra RD. Single-cell RNA-seq uncovers a robust transcriptional response to morphine by glia. Cell Rep. 2018;24:3619–3629.e4.

pubmed: 30257220 pmcid: 6357782 doi: 10.1016/j.celrep.2018.08.080

Karagiannis TT, Cleary JP, Gok B, Henderson AJ, Martin NG, Yajima M, et al. Single cell transcriptomics reveals opioid usage evokes widespread suppression of antiviral gene program. Nat Commun. 2020;11:2611.

pubmed: 32457298 pmcid: 7250875 doi: 10.1038/s41467-020-16159-y

Ho MF, Zhang C, Moon I, Zhu X, Coombes BJ, Biernacka J, et al. Single cell transcriptomics reveals distinct transcriptional responses to oxycodone and buprenorphine by iPSC-derived brain organoids from patients with opioid use disorder. Mol Psychiatry. 2022. https://doi.org/10.1038/S41380-022-01837-8 .

doi: 10.1038/S41380-022-01837-8 pubmed: 36543923 pmcid: 10588459

Dang J, Tiwari SK, Agrawal K, Hui H, Qin Y, Rana TM. Glial cell diversity and methamphetamine-induced neuroinflammation in human cerebral organoids. Mol Psychiatry. 2021;26:1194–207.

pubmed: 32051547 doi: 10.1038/s41380-020-0676-x

Wei Y, Ho YC. Interferon opens up: HIV-induced inflammation reconfigures 3D chromatin conformation and affects where HIV integrates. Mol Cell. 2022;82:4585–7.

pubmed: 36525953 pmcid: 9925257 doi: 10.1016/j.molcel.2022.11.013

Schlachetzki JCM, Zhou Y, Glass CK. Human microglia phenotypes in the brain associated with HIV infection. Curr Opin Neurobiol. 2022;77:102637.

pubmed: 36194988 doi: 10.1016/j.conb.2022.102637

Farhadian SF, Lindenbaum O, Zhao J, Corley MJ, Im Y, Walsh H, et al. HIV viral transcription and immune perturbations in the CNS of people with HIV despite ART. JCI Insight. 2022;7:e160267.

pubmed: 35801589 pmcid: 9310520 doi: 10.1172/jci.insight.160267

Zheng J, Ru W, Adolacion JR, Spurgat MS, Liu X, Yuan S, et al. Single-cell RNA-seq analysis reveals compartment-specific heterogeneity and plasticity of microglia. IScience. 2021;24:102186.

pubmed: 33718838 pmcid: 7921843 doi: 10.1016/j.isci.2021.102186

Farhadian SF, Mehta SS, Zografou C, Robertson K, Price RW, Pappalardo J, et al. Single-cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid during virologically suppressed HIV. JCI Insight. 2018;3:e121718.

pubmed: 30232286 pmcid: 6237230 doi: 10.1172/jci.insight.121718

Deak JD, Zhou H, Galimberti M, Levey DF, Wendt FR, Sanchez-Roige S, et al. Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci. Mol Psychiatry. 2022;27:3970–9.

pubmed: 35879402 pmcid: 9718667 doi: 10.1038/s41380-022-01709-1

Zhou H, Sealock JM, Sanchez-Roige S, Clarke TK, Levey DF, Cheng Z, et al. Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. Nat Neurosci. 2020;23:809–18.

pubmed: 32451486 pmcid: 7485556 doi: 10.1038/s41593-020-0643-5

Xu K, Li B, McGinnis KA, Vickers-Smith R, Dao C, Sun N, et al. Genome-wide association study of smoking trajectory and meta-analysis of smoking status in 842,000 individuals. Nat Commun. 2020;11:5302.

pubmed: 33082346 pmcid: 7598939 doi: 10.1038/s41467-020-18489-3

Vigorito M, Connaghan KP, Chang SL. The HIV-1 transgenic rat model of neuroHIV. Brain Behav Immun. 2015;48:336–49.

pubmed: 25733103 pmcid: 4753047 doi: 10.1016/j.bbi.2015.02.020

Gu CJ, Borjabad A, Hadas E, Kelschenbach J, Kim BH, Chao W, et al. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment. PLoS Pathog. 2018;14:e1007061.

pubmed: 29879225 pmcid: 5991655 doi: 10.1371/journal.ppat.1007061

Heithoff AJ, Totusek SA, Le D, Barwick L, Gensler G, Franklin DR, et al. The integrated National NeuroAIDS Tissue Consortium database: a rich platform for neuroHIV research. Database. 2019;2019. https://doi.org/10.1093/database/bay134 .

Morgello S, Gelman BB, Kozlowski PB, Vinters HV, Masliah E, Cornford M, et al. The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol. 2001;27:326–35.

pubmed: 11532163 doi: 10.1046/j.0305-1846.2001.00334.x

Bakken TE, Jorstad NL, Hu Q, Lake BB, Tian W, Kalmbach BE, et al. Comparative cellular analysis of motor cortex in human, marmoset and mouse. Nature. 2021;598:111–9.

pubmed: 34616062 pmcid: 8494640 doi: 10.1038/s41586-021-03465-8

Crow M, Paul A, Ballouz S, Huang ZJ, Gillis J. Characterizing the replicability of cell types defined by single cell RNA-sequencing data using MetaNeighbor. Nat Commun. 2018;9:1–12.

doi: 10.1038/s41467-018-03282-0

Zhang M, Pan X, Jung W, Halpern AR, Eichhorn SW, Lei Z, et al. Molecularly defined and spatially resolved cell atlas of the whole mouse brain. Nature. 2023;624:343–54.

pubmed: 38092912 pmcid: 10719103 doi: 10.1038/s41586-023-06808-9

Langlieb J, Sachdev NS, Balderrama KS, Nadaf NM, Raj M, Murray E, et al. The molecular cytoarchitecture of the adult mouse brain. Nature. 2023;624:333–42.

pubmed: 38092915 pmcid: 10719111 doi: 10.1038/s41586-023-06818-7

Zhou J, Zhang Z, Wu M, Liu H, Pang Y, Bartlett A, et al. Brain-wide correspondence of neuronal epigenomics and distant projections. Nature. 2023;624:355–65.

pubmed: 38092919 pmcid: 10719087 doi: 10.1038/s41586-023-06823-w

Gabitto M, Travaglini K, Ariza J, Kaplan E, Long B, Rachleff V, et al. Integrated multimodal cell atlas of Alzheimer’s disease. Res Sq. 2023. https://doi.org/10.21203/RS.3.RS-2921860/V1 .

Mathys H, Peng Z, Boix CA, Victor MB, Leary N, Babu S, et al. Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer’s disease pathology. Cell. 2023;186:4365–85.e27.

pubmed: 37774677 doi: 10.1016/j.cell.2023.08.039

Ruzicka WB, Mohammadi S, Fullard JF, Davila-Velderrain J, Subburaju S, Reed Tso D, et al. Single-cell multi-cohort dissection of the schizophrenia transcriptome. 2022. https://doi.org/10.1101/2022.08.31.22279406 .

Wamsley B, Bicks L, Cheng Y, Kawaguchi R, Quintero D, Grundman J, et al. Molecular cascades and cell-type specific signatures in ASD revealed by single cell genomics. BioRxiv. 2023. https://doi.org/10.1101/2023.03.10.530869 .

doi: 10.1101/2023.03.10.530869 pubmed: 36945369 pmcid: 10029000

Nagy C, Maitra M, Suderman M, Theroux J-F, Mechawar N, Ragoussis J, et al. Single-nucleus RNA sequencing shows convergent evidence from different cell types for altered synaptic plasticity in major depressive disorder. BioRxiv. 2018. https://doi.org/10.1101/384479 .

Gandal M, Haney J, Parikshak N, Virpi L. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science (1979). 2018;359:693–7.

Nano PR, Fazzari E, Azizad D, Nguyen CV, Wang S, Kan RL, et al. A meta-atlas of the developing human cortex identifies modules driving cell subtype specification. BioRxiv. 2023. https://doi.org/10.1101/2023.09.12.557406 .

doi: 10.1101/2023.09.12.557406 pubmed: 37745597 pmcid: 10515829

Sonthalia S, Li G, Blanco XM, Casella A, Liu J, Stein-O’brien G, et al. in silico transcriptome dissection of neocortical excitatory neurogenesis via joint matrix decomposition and transfer learning. https://doi.org/10.1101/2024.02.26.581612 .

Wilkinson MD, Dumontier M, Aalbersberg IJ, Appleton G, Axton M, Baak A, et al. Comment: The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 2016;3:160018.

pubmed: 26978244 pmcid: 4792175 doi: 10.1038/sdata.2016.18

Ament SA, Adkins RS, Carter R, Chrysostomou E, Colantuoni C, Crabtree J, et al. The neuroscience multi-omic archive: a BRAIN initiative resource for single-cell transcriptomic and epigenomic data from the mammalian brain. Nucleic Acids Res. 2023;51:D1075–D1085.

pubmed: 36318260 doi: 10.1093/nar/gkac962

Orvis J, Gottfried B, Kancherla J, Adkins RS, Song Y, Dror AA, et al. gEAR: Gene Expression Analysis Resource portal for community-driven, multi-omic data exploration. Nature Methods. 2021;18:843–4.

pubmed: 34172972 pmcid: 8996439 doi: 10.1038/s41592-021-01200-9

The single-cell opioid responses in the context of HIV (SCORCH) consortium.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Subventions

Informations de copyright

Références

Auteurs

Classifications MeSH